Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Cited by (791)

Items 301–400 of 791

1. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
   Julia Kallenbach, Golnaz Atri Roozbahani, Mehdi Heidari Horestani, Aria Baniahmad · 2022 · Cell & Bioscience
2. Taurine from tumour niche drives glycolysis to promote leukaemogenesis
   Sonali Sharma, Benjamin J. Rodems, Cameron D. Baker, Christina M. Kaszuba, Edgardo I. Franco, Bradley R. Smith, Takashi Ito, Kyle Swovick, Kevin A. Welle, Yi Zhang et al. · 2025 · Nature
3. Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
   Eugine Lee, Susan Ha, Susan K. Logan · 2015 · PLoS ONE
4. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
   Han Guan, Chunhui Liu, Fang Fang, Yeqing Huang, Tao Tao, Zhixin Ling, Zonghao You, Xu Han, Shuqiu Chen, Bin Xu et al. · 2017 · Oncotarget
5. Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy
   Xu Wu, Shengpeng Wang, Mingxing Li, Anqi Wang, Yangyang Y. Zhou, Peng Li, Yitao Wang · 2017 · Nanoscale
6. Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma
   Sara Laudato, Ana M. Aparicio, Filippo G. Giancotti · 2019 · Trends in cancer
7. A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects
   Ho Jin Lee, Hye-Young Min, Young-Sik Yong, Jihyae Ann, Cong-Truong Nguyen, Minh Thanh La, Seung Yeob Hyun, Huong Thuy Le, Hyewon Kim, Hyuk-Jin Kwon et al. · 2021 · Theranostics
8. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer
   Ryuta Watanabe, Noriyoshi Miura, Mie Kurata, Riko Kitazawa, Tadahiko Kikugawa, Takashi Saika · 2023 · International Journal of Molecular Sciences
9. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches
   Tuula Anneli Salo, Marilena Vered, Ibrahim Olajide Bello, Pia Nyberg, Carolina Cavalcante Bitu, Ayelet Zlotogorski‐Hurvitz, Dan Dayan · 2014 · Experimental Cell Research
10. Dormancy in solid tumors: implications for prostate cancer
    Nazanin S. Ruppender, Colm M. Morrissey, Paul H. Lange, Robert L. Vessella · 2013 · Cancer and Metastasis Reviews
11. Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
    Andrea Morandi, Elisa Giannoni, Paola Chiarugi · 2016 · Trends in cancer
12. Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
    Ryu Kanzaki, Hisamichi Naito, Kazuyoshi Kise, Kazuhiro Takara, Daisuke Eino, Masato Minami, Yasushi Shintani, Soichiro Funaki, Tomohiro Kawamura, Tōru Kimura et al. · 2017 · Scientific Reports
13. Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
    Casey D. Stefanski, Jenifer R. Prosperi · 2020 · International Journal of Molecular Sciences
14. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
    Bangwei Fang, Ying Lu, Xiaomeng Li, Wei Yu, Dingwei Ye, Gong‐Hong Wei, Yao Zhu · 2024 · Prostate Cancer and Prostatic Diseases
15. Revisiting ovarian cancer microenvironment: a friend or a foe?
    Boyi Zhang, Fei Chen, Qixia Xu, Liu Han, Jiaqian Xu, Libin Gao, Xiaochen Sun, Yiwen Li, Yan Li, Min Qian et al. · 2017 · Protein & Cell
16. CD133-positive cancer stem cells from colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile
    Vincent Zangiacomi, Kenichi Urakami, Koji Maruyama, Ken Yamaguchi, Masatoshi Kusuhara · 2014 · Genes & Cancer
17. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer
    Sheng Zheng, Jiafeng Wang, Ning Ding, Wenwen Chen, Hong-Da Chen, Meng Xue, Fei Chen, Jiaojiao Ni, Zhuo Wang, Zhenghua Lin et al. · 2021 · Journal of Nanobiotechnology
18. Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer
    Emma Nolan, Ilaria Malanchi · 2021 · Seminars in Immunology
19. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness
    Jingjing Li, Tianjie Pu, Lijuan Yin, Qinlong Li, Chun‐Peng Liao, Boyang Jason Wu · 2020 · Oncogene
20. PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer
    Xiaoting Li, Tian Fang, Sen Xu, Ping Jin, Dongchen Zhou, Zhengzheng Wang, Huayi Li, Zongyuan Yang, Gang Chen, Zheng Xu et al. · 2021 · npj Precision Oncology
21. Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils
    Massimo Russo, Claudia Nastasi · 2022 · Frontiers in Oncology
22. The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
    Jian Zheng, Hua Hao · 2024 · Frontiers in Oncology
23. Cancer Stem Cells, Pluripotency, and Cellular Heterogeneity
    Yaser Atlasi, Leendert H. J. Looijenga, Riccardo Fodde · 2014 · Current topics in developmental biology/Current Topics in Developmental Biology
24. Host effects contributing to cancer therapy resistance.
    Katz, Ofrat Beyar, Shaked, Yuval · 2015 · Drug Resistance Updates
25. The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer
    Carolina Soekmadji, Colleen C. Nelson · 2015 · BioMed Research International
26. The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing
    Alexander William Wyatt, Fan Mo, Yuzhuo Z. Wang, Colin C. Collins · 2013 · Asian Journal of Andrology
27. Periprostatic Adipose Tissue and Prostate Cancer Progression: New Insights into the Tumor Microenvironment
    Paul Toren, Vasundara Venkateswaran · 2013 · Clinical Genitourinary Cancer
28. STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
    Ji Sun Lee, Ju-Hee Kang, Hye‐Jin Boo, Su-Jung Hwang, Sungyoul Hong, Su-Chan Lee, Young-Jun Park, Tae-Moon Chung, Hyewon Youn, Seung Mi Lee et al. · 2015 · Nature Communications
29. Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies
    Lu Han, Jiaqian Xu, Qing Rong Xu, B. Zhang, Eric W.‐F. Lam, Yu Sun · 2017 · Medicinal Research Reviews
30. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma
    Ferdinand Wagner, Boris Michael Holzapfel, Jacqui McGovern, Alimohammad Shafiee, Jeremy Baldwin, Laure C. Martine, Christoph A. Lahr, Felix M. Wunner, Thor Friis, Onur Bas et al. · 2018 · Biomaterials
31. Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation
    Eike-Benjamin Braune, Anita Seshire, Urban Lendahl · 2018 · Biomedicines
32. Emerging targets in cancer drug resistance
    Shashank Kumar, Prem Prakash Kushwaha, Sanjay Gupta · 2019 · Cancer Drug Resistance
33. Retooling Cancer Nanotherapeutics’ Entry into Tumors to Alleviate Tumoral Hypoxia
    Xiao Jun Sun, Nengyi Ni, Yanling Ma, Yan Wang, David Tai Leong · 2020 · Small
34. The Hallmarks of Cancer as Ecologically Driven Phenotypes
    Jason A. Somarelli · 2021 · Frontiers in Ecology and Evolution
35. The tumor microenvironment: a key player in multidrug resistance in cancer
    Lingnan Meng, Ying Zheng, Hao Liu, Daiming Fan · 2024 · ONCOLOGIE
36. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors
    M. Ehnman, A. Östman · 2014 · Expert Opinion on Investigational Drugs
37. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
    Nicola Graham, Bin‐Zhi Qian · 2018 · International Journal of Molecular Sciences
38. Misrepair in Context: TGFβ Regulation of DNA Repair
    Qi Liu, Kirsten Anne Pagaduan Lopez, John P. Murnane, Timothy C. Humphrey, Mary Helen Barcellos‐Hoff · 2019 · Frontiers in Oncology
39. Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
    Dingyu Hu, Shunling Yuan, Jing Zhong, Zhaoping Liu, Yanyan Wang, Li Liu, Junjun Li, Feng Wen, Jing Liu, Ji Zhang · 2021 · Pharmacology & Therapeutics
40. The Tumor Microenvironment at a Turning Point—Knowledge Gained Over the Last Decade, and Challenges and Opportunities Ahead: A White Paper from the NCI TME Network
    Yves Albert DeClerck, Kenneth J. Pienta, Elisa C. Woodhouse, Dinah S. Singer, Suresh Mohla · 2017 · Cancer Research
41. Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation
    Hong‐Lin Cheng, Xin Li, Chuanlin Wang, Yujie Chen, Sijiang Li, Jincai Tan, Bing Tan, Yunfeng He · 2018 · Cancer Letters
42. Therapy-induced senescence is a transient drug resistance mechanism in breast cancer
    Eszter Bajtai, Csaba Kiss, Éva Bakos, Tamás Langó, Anna Lovrics, Éva Schád, Viktória Tisza, Károly Hegedűs, Péter Fürjes, Zoltán Szabó et al. · 2025 · Molecular Cancer
43. Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer
    Laurine Verset, Joke Tommelein, Xavier Moles Lopez, Christine Decaestecker, Tom Boterberg, Elly De Vlieghere, Isabelle J. Salmon, Marc M. K. Mareel, Marc Bracke, Olivier De Wever et al. · 2015 · Radiotherapy and Oncology
44. A reciprocal role of prostate cancer on stromal DNA damage
    Jheelam Banerjee, Rajeev Mishra, Xuedong Li, Roger S. Jackson, Aryan Sharma, Neil A. Bhowmick · 2013 · Oncogene
45. FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
    Julienne L. Carstens, Payam Shahi, Susan Van Tsang, Billie Smith, Chad J. Creighton, Yiqun Zhang, Amber Seamans, Mamatha R. Seethammagari, Indira Vedula, Jonathan M. Levitt et al. · 2013 · Cancer Research
46. The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment
    Bo Ma, Alan H. Wells, Amanda M. Clark · 2019 · Seminars in Cancer Biology
47. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
    Varun V. Prabhu, Amriti R. Lulla, Neel S. Madhukar, Marie D. Ralff, Dan Zhao, Christina Leah B. Kline, A. Pieter J. van den Heuvel, Avital Lev, Mathew J. Garnett, Ultan McDermott et al. · 2017 · PLoS ONE
48. Deconstructing tumor heterogeneity: the stromal perspective
    Renee E. Vickman, Douglas V. Faget, Philip A. Beachy, David J. Beebe, Neil A. Bhowmick, Edna Cukierman, Wu-Min Deng, James G. Granneman, Jeffrey Hildesheim, Raghu Kalluri et al. · 2020 · Oncotarget
49. Mechanisms of Hydroxyurea‐Induced Cellular Senescence: An Oxidative Stress Connection?
    Sunčica Kapor, Vladan P. Čokić, Juan Francisco Santibanez · 2021 · Oxidative Medicine and Cellular Longevity
50. Canonical Wnt signaling regulates Nkx3.1 expression and luminal epithelial differentiation during prostate organogenesis
    Marianna Kruithof‐de Julio, Maho Shibata, Nishita Desai, Melissa Reynon, M. Vivienne Halili, Yaping Hu, Sandy M. Price, Cory T. Abate-Shen, Michael M. Shen · 2013 · Developmental Dynamics
51. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16
    Ana Ramı́rez de Molina, Teodoro Vargas, Susana Molina, Jenifer Sánchez, Jorge Martínez-Romero, Margarita González‐Vallinas, Roberto Martín‐Hernández, Ruth Sánchez‐Martínez, Marta Gómez de Cedrón, Alberto Dávalos et al. · 2015 · Journal of Pharmacology and Experimental Therapeutics
52. Role of the host stroma in cancer and its therapeutic significance
    David G. Jackson · 2013 · Cancer and Metastasis Reviews
53. Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation
    Mark Borris D. Aldonza, Ji‐Young Hong, Sang Kook Lee · 2017 · Experimental & Molecular Medicine
54. Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
    Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, Joonas Uusi-Mäkelä, Kirsi Johanna Granberg, Matti Nykter, Alfonso Urbanucci · 2021 · Cancers
55. Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors
    Chuan-Shi He, Linlin Wang, Ling Li, Gui-Quan Zhu · 2021 · Translational Oncology
56. Wnt Signaling in the Breast: From Development to Disease
    Willy Antoni Abreu de Oliveira, Youssef El Laithy, A. Bruna, D. Annibali, F. Lluis · 2022 · Frontiers in Cell and Developmental Biology
57. Amphiregulin in Cancer: New Insights for Translational Medicine
    Qixia Xu, Paul J. Chiao, Yu Sun · 2016 · Trends in cancer
58. Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation
    Xiaobin Ma, Xinhua Pan, Yinglei Wei, Binhe Tan, Linli Yang, Hua Ren, Min Qian, Bing Du · 2016 · Oncotarget
59. Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
    Jolieke G. van Oosterwijk, Daelynn R. Buelow, Christina Diane Drenberg, Aksana Vasilyeva, Lie Li, Lei Shi, Yong‐Dong Wang, David Finkelstein, Sheila A. Shurtleff, Laura J. Janke et al. · 2017 · Journal of Clinical Investigation
60. Upregulating MMP‑1 in carcinoma‑associated fibroblasts reduces the efficacy of Taxotere on breast cancer synergized by Collagen IV
    Qingyu Cui, Bixiao Wang, Kaifu Li, Haichen Sun, Hai Tao, Yan Zhang, Hua Kang · 2018 · Oncology Letters
61. Ready player one? Autophagy shapes resistance to photodynamic therapy in cancers
    Xian Duan, Bo Chen, Yanan Cui, Lin Zhou, Chenkai Wu, Zhulin Yang, Yu Wen, Xiongying Miao, Qinglong Li, Li Xiong et al. · 2018 · APOPTOSIS
62. Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
    Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben, Zhongkai Gu, Joshua W. Russo, David Johnson Einstein, Huihui Ye et al. · 2022 · Cancer Research
63. Fibrous stroma: Driver and passenger in cancer development
    Vandana Sharma, Joshua Letson, Saori Furuta · 2022 · Science Signaling
64. Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
    Gábor Valcz, Ferenc Sípos, Zsolt Tulassay, Bela Akos Molnar, Yukako Yagi · 2014 · Journal of Clinical Pathology
65. Bidirectional cross talk between patient‐derived melanoma and cancer‐associated fibroblasts promotes invasion and proliferation
    Benjamin Izar, Cailin E. Joyce, Stephanie L. Goff, Nancy L. Cho, Parin Shah, Gaurav Sharma, Jingjing Li, Nageatte Ibrahim, Jason S. Gold, Frank Stephen Hodi et al. · 2016 · Pigment Cell & Melanoma Research
66. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer
    Yongjiang Li, Junyong Wu, Jiemin Wang, Daxiong Xiang · 2020 · Journal of Controlled Release
67. Lighting up arginine metabolism reveals its functional diversity in physiology and pathology
    Rui Li, Yan Li, Kun Jiang, Lijuan Zhang, Ting Li, Aihua Zhao, Zhuo Zhang, Yale Xia, Kun Ge, Yaqiong Chen et al. · 2024 · Cell Metabolism
68. Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age‐Related Conditions in Mice
    Hongwei Zhang, Qixia Xu, Zhirui Jiang, Rong Sun, Qun Wang, Sanhong Liu, Xin Luan, Judith Campisi, James L. Kirkland, Weidong Zhang et al. · 2025 · Advanced Science
69. Predictive value of epithelial‐mesenchymal‐transition (EMT) signature and PARP‐1 in prostate cancer radioresistance
    Timothy W. Stark, Patrick Joseph Hensley, Amanda Spear, Hong Pu, Stephen E. Strup, Natasha Kyprianou · 2017 · The Prostate
70. Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules
    Tan Yang, Yuyuan Chen, Pengxuan Zhao, Huiying Xue, Jia You, Bin Li, Yong Liu, Chuanchuan He, Xiaojuan Zhang, Lingling Fan et al. · 2018 · Nanomedicine Nanotechnology Biology and Medicine
71. Alerting the immune system to DNA damage: micronuclei as mediators
    Kate M. MacDonald, Soraya Benguerfi, Shane M. Harding · 2020 · Essays in Biochemistry
72. Precise Depletion of Tumor Seed and Growing Soil with Shrinkable Nanocarrier for Potentiated Cancer Chemoimmunotherapy
    Junxia Wang, Song Shen, Jie Li, Ziyang Cao, Xianzhu Yang · 2021 · ACS Nano
73. Modulating tumoral exosomes and fibroblast phenotype using nanoliposomes augments cancer immunotherapy
    May S. Freag, Mostafa T. Mohammed, Arpita Kulkarni, Hagar E. Emam, Krishna Prahlad Maremanda, Ahmed O. Elzoghby · 2024 · Science Advances
74. Coherent light scattering from cellular dynamics in living tissues
    David D. Nolte · 2024 · Reports on Progress in Physics
75. Emerging Roles of Vitamin B12 in Aging and Inflammation
    Sergey Yu. Simonenko, Daria A. Bogdanova, Nikita A. Kuldyushev · 2024 · International Journal of Molecular Sciences
76. Age and metastasis – How age influences metastatic spread in cancer. Colorectal cancer as a model
    Elise Pretzsch, Hanno Nieß, Florian Bösch, Christoph Benedikt Westphalen, Sven Jacob, Jens H. L. Neumann, Jens Werner, Volker Heinemann, Martin Kurt Angele · 2022 · Cancer Epidemiology
77. Fibroblast activation and senescence in oral cancer
    Stephen Stewart Prime, Nicola Cirillo, Yazan Mansour Hassona, D Lambert, Ian Charles Paterson, Massimiliano Mellone, Gareth J. Thomas, Emma Naomi James, Eric Kenneth Parkinson · 2016 · Journal of Oral Pathology and Medicine
78. Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts
    Maria Peiris‐Pagès, Duncan L. Smith, Balázs Győrffy, Federica Sotgia, Michael P. Lisanti · 2015 · Aging
79. New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment
    Haiping Jiang, Sujuan Wang, Xuefei Zhou, Liying Wang, Lidan Ye, Zhuxian Zhou, Jianbin Tang, Xiangrui Liu, Lisong Teng, Youqing Shen · 2018 · Journal of Controlled Release
80. Biomarkers in the path from cellular senescence to frailty
    Marta Zampino, Luigi Ferrucci, Richard D. Semba · 2019 · Experimental Gerontology
81. Fibroblast CEBPD/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4
    Jhih-Ying Chi, Yu‐Wei Hsiao, Hai-Ling Liu, Xin-Juan Fan, Xiang‐Bo Wan, Tsung-Lin Liu, Sheng‐Jou Hung, Yi‐Ting Chen, Hsin-Yin Liang, Ju‐Ming Wang · 2021 · Cell Death Discovery
82. Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
    Laura G.M. Daenen, Julia M. Houthuijzen, Geert A. Cirkel, Jeanine M.L. Roodhart, Yuval Shaked, Emile E. Voest · 2013 · Oncogene
83. Prostate Organogenesis
    Jeffrey C. Francis, Amanda Swain · 2017 · Cold Spring Harbor Perspectives in Medicine
84. ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer
    Ni Chen, Xiaohan Lou, Xiaohan Yao, Linlin Wang, Jiajia Wan, Xixi Duan, Jialu Liang, Kaili Zhang, Yuanyuan Yang, Li Zhang et al. · 2022 · Nature Communications
85. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment
    Mirko Minini, Laura Fouassier · 2023 · Current Oncology
86. Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia
    Davis A. Englund, Alyssa M. Jolliffe, Gabriel J. Hanson, Zaira Aversa, Xu Zhang, Xinyi Jiang, Thomas A. White, Lei Justan Zhang, David G. Monroe, Paul D. Robbins et al. · 2023 · JCI Insight
87. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
    Birong Jiang, Wei Zhang, Xuguang Zhang, Yu Sun · 2024 · Seminars in Cancer Biology
88. Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis
    Jennifer R. Eng, Guillaume Thibault, Shiuh‐Wen Luoh, Joe W. Gray, Young Hwan Chang, Koei Chin · 2019 · Methods in molecular biology
89. Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
    Charlotte Hellmich, Jamie A Moore, Kristian M. Bowles, Stuart A. Rushworth · 2020 · Frontiers in Oncology
90. Targeting Tumor Physical Microenvironment for Improved Radiotherapy
    Jin Wang, Yulong Han, Yuan Li, Fengping Zhang, Mengjiao Cai, Xinyue Zhang, Jie Chen, Chao Ji, Jinlu Ma, Feng Xu · 2022 · Small Methods
91. Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line
    Jennifer J. Parker, Jennifer Clare Jones, Samuel Strober, Susan Jane Knox · 2013 · Clinical Immunology
92. Animal Toxicity of Hairpin Pyrrole-Imidazole Polyamides Varies with the Turn Unit
    Fei Yang, Nicholas George Nickols, Benjamin C. Li, Jerzy O. Szablowski, Shari R Hamilton, Jordan L. Meier, Chieh-Mei Wang, Peter B. Dervan · 2013 · Journal of Medicinal Chemistry
93. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis
    Shahid Hussain, Sonal Saxena, Sameer Shrivastava, Ashok Kumar Mohanty, Sudarshan Kumar, Raj Kumar Singh, Abhinav Kumar, Sajad A. Wani, Ravi Kumar Gandham, Naveen Kumar et al. · 2018 · PLoS ONE
94. Ceramide launches an acute anti‐adhesion pro‐migration cell signaling program in response to chemotherapy
    Daniel Canals, Silvia Salamone, Bruno Jaime Santacreu, Erika Nemeth, Daniel Aguilar, María José Hernandez‐Corbacho, Mohamad M. Adada, Daniela I. Staquicini, Wadih Arap, Renata Pasqualini et al. · 2020 · The FASEB Journal
95. Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
    Shiv Verma, Kumari Sunita Prajapati, Prem Prakash Kushwaha, Mohd Shuaib, Atul Kumar Singh, Shashank Kumar, Sanjay Gupta · 2020 · Cancer Drug Resistance
96. Using 3D in vitro cell culture models in anti-cancer drug discovery
    Sigrid A. Langhans · 2021 · Expert Opinion on Drug Discovery
97. Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance
    Changxu Wang, Qilai Long, Qiang Fu, Qixia Xu, Da Fu, Yan Li, Libin Gao, Jianming Guo, Xiaoling Zhang, Eric W.‐F. Lam et al. · 2022 · Oncogene
98. Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment
    Amy Yimin Wu, David Liao, Thea Dorothy Tlsty, James C. Sturm, Robert H. Austin · 2014 · Interface Focus
99. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review
    Samatha M. Jain, Shruthi Nagainallur Ravichandran, Makalakshmi Murali Kumar, Antara Banerjee, Alexander Sun-Zhang, Hong Zhang, Rupak Pathak, Xiao‐Feng Sun, Surajit Pathak · 2024 · Cancer Biology & Therapy
100. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis
     S H Lee, Richard H. Luong, D. T. Johnson, Gerald R. Cunha, Leena Rivina, Mark L. Gonzalgo, Zijie Sun · 2015 · Oncogene